Pill plus chemo shrank tumors in most advanced pancreatic cancer patients
An experimental daily pill called daraxonrasib, given with chemotherapy, shrank tumors in about six in 10 patients with advanced pancreatic cancer. In one in 12, the cancer could no longer be seen on scans. The early trial had 61 patients. The results were presented on Friday in Barcelona. A larger trial now compares it with chemotherapy alone.
Where this came from. 4 outlets reported this. We read them, then wrote the sixty words above.